The company shipped some 750 vials of testosterone to customers who had instead ordered tirzepatide, the active ingredient in ...

ResMed (RMD) stock falls as Wolfe downgrades due to potential label expansion for Eli Lilly's (LLY) tirzepatide in ...

Many GLP-1 users suddenly discover they don't have as much "food noise" or constant thoughts about eating anymore. They also ...

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

“It is not one-size-fits-all, and every medication can have risks and side effects,” Mao added in a university news release. ...

Meanwhile, Lilly’s 2023 revenue exceeded $34 billion, growing 20% year-over-year. Its tirzepatide brands Mounjaro and ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 597.82% and ...

Eli Lilly and Company’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The ...

Rhythm Pharmaceuticals (RYTM) stock gains as JMP Securities issues a positive view on the company citing its lead product ...

1. Expand Healthy Options: Increase your assortment of low-calorie and high-protein products, such as protein bars and ...